Medtronic (MDT) shares posted seven straight sessions of gains as they closed flat in the green at $90.74 on Thursday, after plunging over 7% in the previous we ...

Brainomix announced today that it entered into a strategic partnership with the Medtronic Neurovascular business unit.

Medtronic, a leader in medical technology and Philips, a leader in health technology announced the signing of a Memorandum of ...

Medtronic announced that investigators enrolled the first patient in a pivotal trial of its Prevail drug-coated balloon (DCB) ...

The strategic partnership aims to increase access to Brainomix's AI technology for stroke treatment in Western Europe.

Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, ...

Dr Michalis Papadakis, CEO and Co-Founder of Brainomix, highlighted the shared vision of both companies: “This partnership ...

The strong dollar has been a continuing nuisance for U.S. companies with global operations, which convert their earnings ...

Wealthspire Advisors LLC lessened its stake in shares of Medtronic plc (NYSE:MDT – Free Report) by 40.6% during the 4th ...

Brainomix, a pioneer in stroke AI imaging software and European market leader, has announced a strategic partnership with Medtronic Neurovascular ...

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...

ViCentra announced today that it appointed Tom Arnold as its new CEO to accelerate growth with the Kaleido automated insulin ...